Title:
抗菌剤及び抗炎症剤を含む眼内投与のための医薬組成物
Document Type and Number:
Japanese Patent JP7362870
Kind Code:
B2
Abstract:
Pharmaceutical compositions for intraocular injection are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as triamcinolone), at least one pharmaceutically acceptable excipient and a pharmaceutically acceptable carrier. Methods for fabricating the compositions and using them for intraocular injections are also described.
More Like This:
Inventors:
Jeffrey T. Riegner
John Scott Carrollchik
Bernard Kobarsky
Richard Dilzer
Karan Peters
John Scott Carrollchik
Bernard Kobarsky
Richard Dilzer
Karan Peters
Application Number:
JP2022157885A
Publication Date:
October 17, 2023
Filing Date:
September 30, 2022
Export Citation:
Assignee:
NOVEL DRUG SOLUTIONS LLC
EYE CARE NORTHWEST, PA
EYE CARE NORTHWEST, PA
International Classes:
A61K31/573; A61K31/4709; A61K31/505; A61K31/546; A61K31/7036; A61K38/12; A61K47/02; A61K47/10; A61K47/12; A61K47/26; A61P27/02; A61P29/00; A61P31/04
Domestic Patent References:
| JP2013508381A | ||||
| JP2002522373A | ||||
| JP11092368A | ||||
| JP2003176228A |
Other References:
LIPNER, M.,Perioperative pharmacology Bucking the drop trend,[ONLINE],2012年05月,http://eyeworld.org/article-bucking-the-drop-trend,検索日[2017年10月5日]
SAKALAR, Y. B. et al,Treatment of Experimental Bacillus cereus Endophthalmitis Using Intravitreal Moxifloxacin With or W,J. Ocul. Pharmacol. Ther.,2011年,Vol.27 No.6,pp.593-598,http://dx.doi.org/10.1089/JOP.2011.0021
ERMIS, S. S. et al,Treatment of Staphylococcus Epidermidis Endophthalmitis with Intravitreal Moxifloxacin in a Rabbit M,Tohoku J. Exp. Med.,2005年,Vol.205,pp.223-229
PAGANELLI, F. et al,A Single Intraoperative Sub-Tenon's Capsule Injection of Triamcinolone and Ciprofloxacin in a Contro,Invest. Ophthalmol. Vis. Sci.,2009年,Vol.50 No.7,pp.3041-3047
ANGELUCCI, D.,Best Paper Of Session Intracameral injection studied to replace post-op eyedrops,[ONLINE],2006年01月,http://www.eyeworld.org/article.php?sid=2918,検索日[2017年10月5日]
WISKUR, B. J. et al,Toward Improving Therapeutic Regimens for Bacillus Endophthalmitis,Invest. Ophthalmol. Vis. Sci.,2008年,Vol.49 No.4,pp.1480-1487
SAKALAR, Y. B. et al,Treatment of Experimental Bacillus cereus Endophthalmitis Using Intravitreal Moxifloxacin With or W,J. Ocul. Pharmacol. Ther.,2011年,Vol.27 No.6,pp.593-598,http://dx.doi.org/10.1089/JOP.2011.0021
ERMIS, S. S. et al,Treatment of Staphylococcus Epidermidis Endophthalmitis with Intravitreal Moxifloxacin in a Rabbit M,Tohoku J. Exp. Med.,2005年,Vol.205,pp.223-229
PAGANELLI, F. et al,A Single Intraoperative Sub-Tenon's Capsule Injection of Triamcinolone and Ciprofloxacin in a Contro,Invest. Ophthalmol. Vis. Sci.,2009年,Vol.50 No.7,pp.3041-3047
ANGELUCCI, D.,Best Paper Of Session Intracameral injection studied to replace post-op eyedrops,[ONLINE],2006年01月,http://www.eyeworld.org/article.php?sid=2918,検索日[2017年10月5日]
WISKUR, B. J. et al,Toward Improving Therapeutic Regimens for Bacillus Endophthalmitis,Invest. Ophthalmol. Vis. Sci.,2008年,Vol.49 No.4,pp.1480-1487
Attorney, Agent or Firm:
Norito Yamao
Sei Morimoto
Nobuhiko Akiyama
Sei Morimoto
Nobuhiko Akiyama
Previous Patent: Compositions and systems for measuring renal function
Next Patent: Eyepiece optical system and observation device having the same
Next Patent: Eyepiece optical system and observation device having the same